---
title: "Kepler Capital  Sticks to Its Hold Rating for Aena SA (0R4Y)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280549558.md"
description: "Kepler Capital analyst Prieto Luis has maintained a Hold rating on Aena SA, setting a price target of €25.70, while the shares closed at €25.23. Luis, a 5-star analyst, has an average return of 16.4% and a 71.60% success rate. Additionally, Citi's Ashish Khetan also issued a Hold rating on March 10, while UBS maintained a Buy rating on March 23."
datetime: "2026-03-26T01:36:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280549558.md)
  - [en](https://longbridge.com/en/news/280549558.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280549558.md)
---

# Kepler Capital  Sticks to Its Hold Rating for Aena SA (0R4Y)

Kepler Capital analyst Prieto Luis maintained a Hold rating on Aena SA on March 24 and set a price target of €25.70. The company’s shares closed last Tuesday at €25.23.

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Luis is a 5-star analyst with an average return of 16.4% and a 71.60% success rate. Luis covers the Industrials sector, focusing on stocks such as Sacyr SA, Hochtief, and Ferrovial.

In addition to Kepler Capital , Aena SA also received a Hold from Citi’s Ashish Khetan in a report issued on March 10. However, on March 23, UBS maintained a Buy rating on Aena SA (LSE: 0R4Y).

### Related Stocks

- [ANYYY.US](https://longbridge.com/en/quote/ANYYY.US.md)

## Related News & Research

- [Aena SME S.A. ADR reports Q1 results](https://longbridge.com/en/news/284514372.md)
- [UBS Reaffirms Their Buy Rating on Aena SA (0R4Y)](https://longbridge.com/en/news/280218285.md)
- [ZenaTech Advances Three ZenaDrone Defense Platforms Through Blue UAS Certification Pathway | ZENA Stock News](https://longbridge.com/en/news/286910480.md)
- [Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing](https://longbridge.com/en/news/286872009.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)